Design and Evaluation of Ophthalmic Pharmaceutical Products

New methods are presented for simulating steady-state drug concentration in vitreous, choroid, and sclera from an intravitreal device. Clearance by choroidal flow and intraocular pressure (IOP) -induced Darcy hydraulic flow are included. Two methods are proposed for modeling the vasculature using simple one-dimensional models for simulating drug concentration profiles from intravitreal devices. The finite choroid method adds a concentration-dependent sink term to the convective diffusion equation, allowing for a continuous but rapid decrease in concentration throughout the choroid region. The infinitesimal choroid method uses a combination of a simple flux boundary condition and a redefinition of the dependent variable to account for the impact of the vascular drain by a discontinuous drop in concentration across the exterior vitreous boundary. This eliminates the need for a choroidal region, reducing finite element memory requirements, enabling the choroid to be made arbitrarily thin. The impact of permeating fluid induced by IOP on convection was examined, using hydraulic coefficients for ocular tissue recently made available [Xu, J. et al., Pharm. Res. 17:664-669 (2000)], allowing for drug efflux through the outer sclera. Transport becomes diffusion limited at high vascular clearance. Hydraulic flow restricts the range in concentration predicted in the vitreous compared to zero flow. Hydraulic influences for small, rapidly cleared drugs can be neglected.

show abstract

An Updated Patent Review on Ocular Drug Delivery Systems with Potential for Commercial Viability

Srivastava

Pathak²

2011

DDF

View full text Add to dashboard Cite

The eye due to its special attributes is an effortlessly accessible location for topical drug administration. Topical administration not only provides local targeting of drugs but also offers a better control over the systemic delivery. Bioavailability of drugs from ocular dosage forms is dependent to the precorneal loss factors (physiological and anatomical constraints of eye) thus, very small fraction of the drug is absorbed through ocular route. The effective dose of medication administered ophthalmically may be altered by changing the formulation. Various research reports have been documented for ocular drug delivery, both on academic level as well as commercial level resulting in augmented increase in the numbers of patents in this field. The primary objective of the present review is to provide an overview of the ocular drug delivery systems with special emphasis on the intellectual aspects of these systems. This paper also attempts to extend the information on ocular drug delivery systems already existing in the literature by focusing on the update on the patents granted as well as applications published for these systems during the last decade.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Design and Evaluation of Ophthalmic Pharmaceutical Products

Cited by 4 publications

References 22 publications

Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants

Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants

Finite and Infinitesimal Representations of the Vasculature: Ocular Drug Clearance by Vascular and Hydraulic Effects

An Updated Patent Review on Ocular Drug Delivery Systems with Potential for Commercial Viability

Contact Info

Product

Resources

About